Document Detail

Differential targets and subcellular localization of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells.
MedLine Citation:
PMID:  16540473     Owner:  NLM     Status:  MEDLINE    
Synthetic alkyl-lysophospholipids represent a family of promising anticancer drugs that induce apoptosis in a variety of tumor cells. Here we have found a differential subcellular distribution of the alkyl-lysophospholipid edelfosine in leukemic and solid tumor cells that leads to distinct anticancer responses. Edelfosine induced rapid apoptosis in human leukemic cells, including acute T-cell leukemia Jurkat and Peer cells, but promoted a late apoptotic response, preceded by G(2)/M arrest, in human solid tumor cells such as cervix epitheloid carcinoma HeLa cells and lung carcinoma A549 cells. c-Jun amino-terminal kinase (JNK) and caspase-3 were accordingly activated at earlier times in edelfosine-treated Jurkat cells as compared with drug-treated HeLa cells. Both leukemic and solid tumor cells took up this alkyl-lysophospholipid and expressed the two putative edelfosine targets, namely cell surface Fas death receptor (also known as APO-1 or CD95) and endoplasmic reticulum CTP: phosphocholine cytidylyltransferase. However, edelfosine was mainly located to plasma membrane lipid rafts in Jurkat and Peer leukemic cells and to endoplasmic reticulum in solid tumor HeLa and A549 cells. Edelfosine induced translocation of Fas, Fas-associated death domain-containing protein, and JNK into membrane rafts in Jurkat cells, but not in HeLa cells. In contrast, edelfosine inhibited phosphatidylcholine biosynthesis in both HeLa and A549 cells, but not in Jurkat or Peer leukemic cells, before the triggering of apoptosis. These data indicate that edelfosine targets two different subcellular structures in a cell type-dependent manner, namely cell surface lipid rafts in leukemic cells and endoplasmic reticulum in solid tumor cells.
Teresa Nieto-Miguel; Consuelo Gajate; Faustino Mollinedo
Related Documents :
16153243 - The amino-terminal non-catalytic region of salmonella typhimurium sigd affects actin or...
6490823 - Diagnosis of fastidious enteric adenoviruses 40 and 41 in stool specimens.
9367433 - Cell morphogenesis of trichomes in arabidopsis: differential control of primary and sec...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-03-15
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  281     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-22     Completed Date:  2006-07-07     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  14833-40     Citation Subset:  IM    
Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD95 / biosynthesis
Antineoplastic Agents / pharmacology*
Caspase 3
Caspases / metabolism
Endoplasmic Reticulum / metabolism
Hela Cells
Jurkat Cells / metabolism
Leukemia / metabolism*,  pathology
Lysophospholipids / chemistry*
MAP Kinase Kinase 4 / metabolism
Membrane Microdomains
Neoplasms / metabolism*
Phospholipid Ethers / pharmacology*
Reg. No./Substance:
0/Antigens, CD95; 0/Antineoplastic Agents; 0/Lysophospholipids; 0/Phospholipid Ethers; 65492-82-2/edelfosine; EC Kinase Kinase 4; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, the...
Next Document:  Syndapin oligomers interconnect the machineries for endocytic vesicle formation and actin polymeriza...